CRISPR Crops Are Growing in Your Country and You Probably Don't Know

CRISPR-edited crops are now in field trials across Europe, the US, and Asia. Here is what they are, what the regulatory landscape looks like, and what's actually being grown.

CRISPR gene editing — the technology for making precise, targeted changes to an organism's existing DNA without necessarily introducing foreign genetic material — has been advancing through agricultural applications at a pace that has exceeded the regulatory frameworks designed to assess them. In 2026, field trials of CRISPR-edited crops are underway in the United States, Japan, China, Australia, and several European countries, growing plants whose genomes have been modified in ways that conventional breeding could theoretically have produced but that took decades instead of years.

The distinction between CRISPR editing and conventional GMO technology is legally and scientifically important. Traditional GMO technology inserts DNA from another organism into the target crop's genome — creating genetic combinations that cannot occur through natural breeding. CRISPR editing, in its most common agricultural applications, modifies the crop's existing genes — switching specific functions on or off, correcting specific mutations, or making changes that could theoretically have occurred through natural mutation. This distinction has produced differential regulatory treatment: Japan, Australia, and the UK have created specific CRISPR crop regulatory pathways that are less burdensome than GMO pathways. The EU's revised framework, adopted in 2024, similarly creates a distinct pathway for targeted genome editing.

The crops currently in field trials span several priority areas. Climate resilience: drought-tolerant wheat varieties with modifications to root water-uptake genes that have shown 30 percent yield improvement in water-limited conditions. Disease resistance: fungal-resistant banana varieties that could provide an alternative to the Cavendish variety threatened by Fusarium wilt. Nutritional enhancement: high-oleic soybean oil with CRISPR-modified fatty acid composition that extends shelf life and removes the need for partial hydrogenation.

For consumers: the regulatory disclosure requirements for CRISPR crops vary enormously by country. In Japan, CRISPR-edited foods are approved without mandatory labelling. In the EU, new labelling requirements for gene-edited foods are being developed. In the US, USDA's approach has been to apply the same regulatory standard as conventional breeding for CRISPR edits that don't introduce foreign DNA.